Recent publications affirm the value of gene expression profile testing in guiding a definitive diagnosis and clinical decision-making in melanocytic lesions of uncertain malignant potential

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced the publication of two recent studies that provide further support for the clinical need of its mypath® melanoma gep test.

CSTL Ratings Summary

CSTL Quant Ranking